Aspirin for secondary prevention of cardiovascular disease in 51 low-, middle-, and high-income countries

SGK Yoo, GS Chung, SK Bahendeka, AM Sibai… - Jama, 2023 - jamanetwork.com
Importance Aspirin is an effective and low-cost option for reducing atherosclerotic
cardiovascular disease (CVD) events and improving mortality rates among individuals with …

Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular disease

A Agarwal, PM Mehta, T Jacobson, NS Shah, J Ye… - Nature medicine, 2024 - nature.com
Fixed-dose combination (FDC) therapy, also known as polypill therapy, targets risk factors
for atherosclerotic cardiovascular disease (ASCVD) and has been proposed as a strategy to …

The polypill and medicines access: two decades and counting

A Rodgers, R Smith - bmj, 2023 - bmj.com
The polypill and medicines access: two decades and counting | The BMJ Skip to main content
Intended for healthcare professionals Access provided by Google Indexer Subscribe My …

A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries

G Satheesh, B Gyawali, MFC Sun, MD Huffman… - Global …, 2024 - pmc.ncbi.nlm.nih.gov
Background: The recent inclusion of polypills—fixed-dose combinations of antihypertensive
medicines and a statin with or without aspirin—in the World Health Organization's Essential …

Achievement of Guideline-Recommended Targets for Secondary Prevention of Cardiovascular Disease in 38 Low-Income and Middle-Income Countries

Z Liu, M Yan, LA Tse, Y Zhu, X Lang, X Liu… - Journal of Epidemiology …, 2024 - Springer
Background This study aimed to estimate the prevalence of achieving the secondary
prevention targets recommended in the World Health Organization (WHO) guidelines for …

The place of polypill in secondary prevention of stroke

DB Ojji, MD Huffman - The Lancet Global Health, 2023 - thelancet.com
People who have had a stroke are confronted with multiple medications and complex
treatment regimens, both associated with low adherence. As a result of barriers at the health …

[HTML][HTML] Integrated Antihypertensive and Statin Treatment Protocols for Cardiovascular Disease Prevention in Low-and Middle-Income Countries

AE Moran, O Aimiosior, R Gupta, A Pathni… - Global …, 2024 - pmc.ncbi.nlm.nih.gov
In low-and middle-income countries where the majority of preventable cardiovascular
disease deaths occur, less than 10% of eligible patients receive statins for primary …

[HTML][HTML] Inclusion of Polypills for Prevention of Cardiovascular Disease in the 23rd World Health Organization Model List of Essential Medicines: A Significant Step …

A Agarwal, MD Huffman - Global Heart, 2024 - ncbi.nlm.nih.gov
This commentary describes the potential impact of inclusion of polypills for prevention of
cardiovascular disease in the 23rd WHO Model List of Essential Medicines, and provides a …

Global NCD policy implementation stalls in the modern era

SP Kishore - The Lancet Global Health, 2023 - thelancet.com
How has policy implementation for non-communicable diseases (NCDs), the leading drivers
of morbidity and mortality globally, fared in the modern era? What are the associations of …